ISRCTN35708246
已完成
未知
PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy): a randomised crossover clinical trial comparing bolus fluorouracil/leucovorin to capecitabine as treatment for moderate to high risk resected colorectal cancer
niversity of Leeds (UK)0 个研究点目标入组 74 人2005年4月19日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- Colorectal cancer
- 发起方
- niversity of Leeds (UK)
- 入组人数
- 74
- 状态
- 已完成
- 最后更新
- 7年前
概览
简要总结
2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18612156
研究者
入排标准
入选标准
- •Patients aged 18 years or above with Dukes? stage C or B colonic or rectal carcinoma, primary fully macroscopically resected (R0 or R1 resection), with no radiological or clinical evidence of metastatic disease (for Dukes? B patients there must be a clinical indication for adjuvant chemotherapy, based on histological risk factors and patient factors) OR full resection of recurrent/metastatic colorectal cancer, if the patient was not previously treated with adjuvant chemotherapy.
排除标准
- •Does not meet inclusion criteria
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk resected colorectal cancer - PACTModerate to high risk resected colorectal cancerEUCTR2005-000686-19-GBniversity of Leeds74
已完成
不适用
Patient preference for colorectal cancer surveillance strategy in inflammatory bowel disease: a discrete choice experimentNL-OMON29540MC Utrecht400
撤回
不适用
Apatinib for Resectable Colorectal CancerApatinibOutcome, FatalColorectal CancerSurgeryAdjuvant ChemotherapyNCT03228043Nanchong Central Hospital
已完成
不适用
Understanding Patient Preference on Colorectal Cancer Screening OptionsColorectal CancerNCT05536713Milton S. Hershey Medical Center297
招募中
2 期
Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal CancerColorectal CancerNCT06698757Yugui Lian96